PRESS RELEASE published on 01/22/2025 at 14:31, 1 year 9 months ago Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (BION) highlighting recent positive developments and implications for the biotech sector. Johnson & Johnson's acquisition of Intra-Cellular Therapies at a premium has boosted BB Biotech's net asset value Acquisition Edison Biotech Sector BB Biotech Johnson & Johnson
BRIEF published on 10/25/2024 at 07:05, 2 years ago BB Biotech AG Releases Interim Report with Positive Net Profit Investment Net Profit Biotech Sector Interim Report BB Biotech
BRIEF published on 10/25/2024 at 07:05, 2 years ago BB Biotech AG publie un rapport intermédiaire avec un bénéfice net positif Investissement Bénéfice Net Rapport Intérimaire Secteur Biotechnologique Biotechnologie BB
BRIEF published on 10/25/2024 at 07:05, 2 years ago BB Biotech: Strategic Portfolio Reallocation Amid Volatile Markets Financial Results Investment Strategy Biotech Sector BB Biotech Portfolio Reallocation
BRIEF published on 10/25/2024 at 07:05, 2 years ago BB Biotech : Réallocation stratégique du portefeuille dans un contexte de marchés volatils Résultats Financiers Stratégie D'investissement Secteur Biotechnologique Biotechnologie BB Réaffectation Du Portefeuille
PRESS RELEASE published on 10/25/2024 at 07:00, 2 years ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report for the first nine months of 2024, showing a net profit and strategic investment details Investment Company Net Profit BB Biotech AG Interim Report Stocks
PRESS RELEASE published on 10/25/2024 at 07:00, 2 years ago BB Biotech: Strategic reallocation of portfolio assets progressing BB Biotech AG reports strategic portfolio reallocation progress in Q3 2024 amid market volatility, focusing on promising biotech investments. Key companies achieve milestones Investment BB Biotech AG Biotech Sector Milestones Portfolio Reallocation
BRIEF published on 10/23/2024 at 10:17, 2 years ago BB Biotech Sees Positive Developments Amid Sector Challenges Investment Opportunity Biotech Sector BB Biotech Share Price Discount RNA Editing
BRIEF published on 10/23/2024 at 10:17, 2 years ago BB Biotech constate une évolution positive malgré les défis du secteur Opportunité D'investissement Secteur Biotechnologique Biotechnologie BB Édition D'ARN Rabais Sur Le Prix De L'action
PRESS RELEASE published on 10/23/2024 at 10:12, 2 years ago Edison issues report on BB Biotech (BION) Edison releases report on BB Biotech, highlighting positive developments in genetic medicine and revenue prospects, offering investment opportunity at a wide discount Investment Opportunity Edison Discount BB Biotech Genetic Medicine
Published on 10/29/2026 at 22:01, 3 hours 1 minute ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended September 30, 2026
Published on 10/29/2026 at 21:30, 3 hours 32 minutes ago Shelfie Announces Amendments to Previously Announced Acquisition of Aspect
Published on 10/29/2026 at 18:30, 6 hours 32 minutes ago Kidoz Inc. Appoints Derek Sentner as Chief Revenue Officer
Published on 10/29/2026 at 16:05, 8 hours 57 minutes ago SouthGobi Announces Date of Special Meeting of Shareholders and The Record Date
Published on 10/29/2026 at 22:25, 2 hours 36 minutes ago SFC Energy continues strong, profitable growth in the first nine months of 2026 – preliminary figures – earnings guidance raised again
Published on 10/29/2026 at 22:21, 2 hours 41 minutes ago EQS-Adhoc: SFC Energy AG raises full-year 2026 earnings guidance again
Published on 10/29/2026 at 21:29, 3 hours 33 minutes ago 2CRSi SA: Publication of the consolidated annual results and the 2025-2026 Annual Financial Report postponed to 30 October 2026
Published on 10/29/2026 at 21:29, 3 hours 33 minutes ago 2CRSi SA: Report de la publication des résultats annuels consolidés et du Rapport Financier Annuel 2025-2026 au 30 octobre 2026
Published on 10/29/2026 at 21:20, 3 hours 42 minutes ago 2CRSi SA: 2CRSi publie les conclusions de l'expert indépendant mandaté à la suite du rapport Grizzly Research et apporte des précisions sur plusieurs communications antérieures
Published on 10/29/2026 at 18:02, 7 hours ago TF1 9M 2026 results - Consolidated financial statements and appendix
Published on 10/29/2026 at 18:02, 7 hours ago Résultats TF1 9M 2026 - Comptes consolidés et annexes aux comptes
Published on 10/29/2026 at 18:00, 7 hours 2 minutes ago GUILLEMOT CORPORATION: THIRD-QUARTER 2026 TURNOVER / Successful new product launches and acceleration of international commercial partnerships
Published on 10/29/2026 at 18:00, 7 hours 2 minutes ago GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2026 / Succès des nouveaux lancements et accélération des partenariats commerciaux internationaux
